• DOI:10.1046/j.1365-2265.1997.3071113.x
Corpus ID: 31976796

Long‐term efficacy and safety of a permeation‐enhanced testosterone transdermal system in hypogonadal men

@article{Arver1997LongtermEA,
  title={Long‐term efficacy and safety of a permeation‐enhanced testosterone transdermal system in hypogonadal men},
  author={S. Arver and A. Dobs and A. Meikle and K. Caramelli and L. Rajaram and S. Sanders and N. Mazer},
  journal={Clinical Endocrinology},
  year={1997},
  volume={47}
}

S. Arver, A. Dobs, +4 authors N. Mazer

Published 1997

Medicine

Clinical Endocrinology

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed

An important aim in treating male hypogonadism is restoration of physiological concentrations of testosterone and its metabolites. We have assessed hormone levels, pharmacokinetics and clinical response, including safety, of a permeation‐enhanced testosterone transdermal system (TTD) in the treatment of hypogonadal men for a 12‐month period.